Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 626 across all filing types
Latest filing 2024-10-20 Regulatory Filings
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Trading Halt 2 pages 554.1KB
Regulatory Filings Classification · 100% confidence The document is a market announcement from Nanoveu Limited regarding a trading halt requested by the company. It references ASX Listing Rule 17.1 and states the halt is pending an announcement about material EMASS benchmark testing results. The document is short (2031 characters), contains no financial data or report content, and is clearly an announcement about a trading halt rather than a financial report or detailed disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance documents that do not fit other specific categories.
2024-10-20 English
EMASS Testing System-on-a-Chip Semiconductor Technology 4 pages 329.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 18 October 2024 from Nanoveu Limited announcing the commencement of benchmark testing for a System-on-a-Chip (SoC) semiconductor technology. It details the benchmarking process, the technology involved, and the strategic importance of the testing. The document is an announcement of a specific event related to the company's technology development and does not contain financial statements, regulatory certifications, voting results, or management changes. It is not a full financial report, earnings release, or investor presentation. The content is focused on a corporate update regarding technology benchmarking and future market positioning. Given the nature of the document as a corporate announcement about a technology milestone and upcoming test results, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2024-10-17 English
Proposed issue of securities - NVU 5 pages 17.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed placement or other type of securities issue by Nanoveu Limited. It includes specifics such as the number of securities, issue date, consideration, and conditions including shareholder approval. The content is focused on announcing a capital raising or securities issuance event rather than presenting financial results or management commentary. It is not a full financial report, earnings release, or regulatory certification. The document matches the description of a Capital/Financing Update, which covers company fundraising and capital structure changes.
2024-10-15 English
Update - Proposed issue of securities - NVU 5 pages 19.0KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX (Australian Securities Exchange) announcement format used for the proposed issue of securities. It details the entity name, announcement type, update to a previous announcement, specifics about the securities to be issued (performance options/rights), number of securities, issue price, conditions, and timetable. The content focuses on capital raising activities and securities issuance rather than financial results, management changes, or legal matters. There is no indication of financial statements or earnings data, nor is it a report or presentation. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes.
2024-10-15 English
Suspension from Quotation 1 page 432.1KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX Compliance regarding the suspension of Nanoveu Limited's securities from quotation. It references a listing rule and a trading halt but does not contain financial data, management discussion, or detailed report content. The document is short (651 characters) and serves as an official notice rather than a report or detailed filing. This fits the definition of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-10-14 English
Nanoveu To Acquire Leading SoC Semiconductor Company 9 pages 432.7KB
M&A Activity Classification · 95% confidence The document is an ASX release dated 15 October 2024 announcing Nanoveu Limited's acquisition of Embedded A.I. Systems Pte. Ltd (EMASS), a semiconductor SoC company. It details the acquisition terms, strategic rationale, technology overview, and leadership changes. It also announces board changes including appointment of an Executive Chairman and issuance of performance rights, and a corporate advisory appointment with related share and option issuances. The content focuses on a corporate transaction (acquisition) and related management and board updates. There are no financial statements or quarterly results, so it is not an earnings release or interim report. It is not a proxy or voting results document. The primary purpose is to announce a merger/acquisition transaction and related corporate governance changes. Therefore, the document fits best under the category of M&A Activity (TAR) for the acquisition announcement and Board/Management Information (MANG) for the board changes and executive appointments. Since the document combines both but the acquisition announcement is the primary focus, the best classification is M&A Activity (TAR). Confidence is high given the detailed acquisition terms and strategic rationale provided.
2024-10-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.